Clinical Trials Browser

Phase 2 × 18-O-demethylcervinomycin A2 × 90 days × Clear all

NCT05351788 2026-05-12

SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05445908 2026-05-08

SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer

Phase 2 Active not recruiting

Triple Negative Breast Neoplasms

NCT07296809 2026-05-08

SKB500 Combinations in Patients With Small Cell Lung Cancer

Phase 2 Recruiting

Small Cell Lung Carcinoma

NCT03848286 2026-05-05

KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence